← Leaderboards
Vito Quaranta
Scripps Research Institute
$19,560,223
Attributed
$24,295,131
Total exposure
15
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4M · FY2005–22$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$51,951,724 · 17
By mechanism
U54$37,581,536 · 8
R01$8,308,599 · 4
U01$5,349,568 · 2
R21$677,021 · 2
R13$35,000 · 1
Top collaborators
- Thomas E Yankeelov12 shared
- Carlos Federico Lopez7 shared
- Erin C Rericha6 shared
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseCellsTumorMathematical ModelProgramsCancer CellMalignant NeoplasmsIn VivoResponsePhenotypeCell LineMeasurementHeterogeneityResistancePharmaceutical PreparationsLinkTumor ProgressionPharmacotherapyGenesIn VitroValidationResearch PersonnelIntegrinsCancer Type
Grant awards (101)
Phenotype Heterogeneity and Dynamics in SCLC$1,546,936
U54 · FY2022 · CA · contact PI
Modeling the SCLC Phenotypic Space$515,617
U54 · FY2022 · CA · contact PI
Administrative Core$199,641
U54 · FY2022 · CA · contact PI
Phenotype Heterogeneity and Dynamics in SCLC$1,759,455
U54 · FY2021 · CA · contact PI
Modeling the SCLC Phenotypic Space$531,756
U54 · FY2021 · CA · contact PI
Phenotype Transitions in Small Cell Lung Cancer$511,899
U01 · FY2021 · CA · contact PI
Administrative Core$364,455
U54 · FY2021 · CA · contact PI
Phenotype Transitions in Small Cell Lung Cancer$8,376
U01 · FY2021 · CA · contact PI
Phenotype Heterogeneity and Dynamics in SCLC$1,732,985
U54 · FY2020 · CA · contact PI
Phenotype Transitions in Small Cell Lung Cancer$569,839
U01 · FY2020 · CA · contact PI
Modeling the SCLC Phenotypic Space$548,781
U54 · FY2020 · CA · contact PI
Administrative Core$302,344
U54 · FY2020 · CA · contact PI
Phenotype Heterogeneity and Dynamics in SCLC$1,735,466
U54 · FY2019 · CA · contact PI
Phenotype Transitions in Small Cell Lung Cancer$657,892
U01 · FY2019 · CA · contact PI
Modeling the SCLC Phenotypic Space$592,269
U54 · FY2019 · CA · contact PI
Quantitative Multiscale Imaging to Optimize Cancer Treatment Strategies$561,337
R01 · FY2019 · CA · contact PI
Administrative Core$212,820
U54 · FY2019 · CA · contact PI
Phenotype Transitions in Small Cell Lung Cancer$49,564
U01 · FY2019 · CA · contact PI
Phenotype Heterogeneity and Dynamics in SCLC$1,688,700
U54 · FY2018 · CA · contact PI
Quantitative Multiscale Imaging to Optimize Cancer Treatment Strategies$570,484
R01 · FY2018 · CA · contact PI
Modeling the SCLC Phenotypic Space$564,861
U54 · FY2018 · CA · contact PI
Phenotype Transitions in Small Cell Lung Cancer$511,899
U01 · FY2018 · CA · contact PI
Image Driven Multi-Scale Modeling to Predict Treatment Response in Breast Cancer$464,348
U01 · FY2018 · CA
Administrative Core$201,528
U54 · FY2018 · CA · contact PI
Quantitative Multiscale Imaging to Optimize Cancer Treatment Strategies$562,502
R01 · FY2017 · CA · contact PI
Phenotype Transitions in Small Cell Lung Cancer$511,899
U01 · FY2017 · CA · contact PI
Image Driven Multi-Scale Modeling to Predict Treatment Response in Breast Cancer$213,114
U01 · FY2017 · CA
Image Driven Multi-Scale Modeling to Predict Treatment Response in Breast Cancer$211,784
U01 · FY2016 · CA
Quantitative Multiscale Imaging to Optimize Cancer Treatment Strategies$152,843
R01 · FY2016 · CA · contact PI
Quantitative Multiscale Imaging to Optimize Cancer Treatment Strategies$621,510
R01 · FY2015 · CA · contact PI
Image Driven Multi-Scale Modeling to Predict Treatment Response in Breast Cancer$541,380
U01 · FY2015 · CA
Inhibition of proliferation by Laminin$170,434
R21 · FY2015 · CA · contact PI
Multiscale Mathematical Modeling of Cancer Progression$1,178,908
U54 · FY2014 · CA · contact PI
Quantitative Multiscale Imaging to Optimize Cancer Treatment Strategies$621,510
R01 · FY2014 · CA · contact PI
Image Driven Multi-Scale Modeling to Predict Treatment Response in Breast Cancer$557,192
U01 · FY2014 · CA
Experimental Component$208,353
U54 · FY2014 · CA · contact PI
Inhibition of proliferation by Laminin$204,587
R21 · FY2014 · CA · contact PI
Theoretical Component$114,403
U54 · FY2014 · CA · contact PI
Administration$102,850
U54 · FY2014 · CA · contact PI
Multiscale Mathematical Modeling of Cancer Progression$1,088,934
U54 · FY2013 · CA · contact PI
Image Driven Multi-Scale Modeling to Predict Treatment Response in Breast Cancer$540,382
U01 · FY2013 · CA
Experimental Component$260,127
U54 · FY2013 · CA · contact PI
Theoretical Component$120,390
U54 · FY2013 · CA · contact PI
Administration$115,966
U54 · FY2013 · CA · contact PI
Multiscale Mathematical Modeling of Cancer Progression$1,070,597
U54 · FY2012 · CA · contact PI
Experimental Component$385,246
U54 · FY2012 · CA · contact PI
Theoretical Component$74,893
U54 · FY2012 · CA · contact PI
Administration$64,671
U54 · FY2012 · CA · contact PI
Multiscale Mathematical Modeling of Cancer Progression$1,327,383
U54 · FY2011 · CA · contact PI
Experimental Component$476,240
U54 · FY2011 · CA · contact PI
Integrins in Cancer Invasion$300,671
R01 · FY2011 · CA · contact PI
Theoretical Component$93,364
U54 · FY2011 · CA · contact PI
Administration$80,189
U54 · FY2011 · CA · contact PI
Multiscale Mathematical Modeling of Cancer Progression$1,137,478
U54 · FY2010 · CA · contact PI
Experimental Component$466,840
U54 · FY2010 · CA · contact PI
Integrins in Cancer Invasion$309,970
R01 · FY2010 · CA · contact PI
Multiscale Mathematical Modeling of Cancer Progression$124,209
U54 · FY2010 · CA · contact PI
Theoretical Component$86,665
U54 · FY2010 · CA · contact PI
Administration$73,953
U54 · FY2010 · CA · contact PI
Multiscale Mathematical Modeling of Cancer Invasion$1,156,870
U54 · FY2009 · CA · contact PI
Integrins in Cancer Invasion$309,970
R01 · FY2009 · CA · contact PI
Multiscale Mathematical Modeling of Cancer Invasion$247,969
U54 · FY2009 · CA · contact PI
Multiscale Mathematical Modeling of Cancer Invasion$111,061
U54 · FY2009 · CA · contact PI
Multiscale Mathematical Modeling of Cancer Invasion$2,313,746
U54 · FY2008 · CA · contact PI
Cancer Biology$817,328
U54 · FY2008 · CA · contact PI
Integrins in Cancer Invasion$309,970
R01 · FY2008 · CA · contact PI
Functional Studies of Laminin-5$276,455
R01 · FY2008 · GM · contact PI
Multiscale Mathematical Modeling of Cancer Invasion$2,065,417
U54 · FY2007 · CA · contact PI
Cancer Biology$803,489
U54 · FY2007 · CA · contact PI
Integrins in Cancer Invasion$308,090
R01 · FY2007 · CA · contact PI
Functional Studies of Laminin-5$276,455
R01 · FY2007 · GM · contact PI
Multiscale Mathematical Modeling of Cancer Invasion$137,175
U54 · FY2007 · CA · contact PI
Multiscale Mathematical Modeling of Cancer Invasion$49,231
U54 · FY2007 · CA · contact PI
Multiscale Mathematical Modeling of Cancer Invasion$2,249,771
U54 · FY2006 · CA · contact PI
Cancer Biology$532,906
U54 · FY2006 · CA · contact PI
Functional Studies of Laminin-5$283,864
R01 · FY2006 · GM · contact PI
INTEGRINS IN CANCER INVASION$76,500
R01 · FY2006 · CA · contact PI
Multiscale Mathematical Modeling of Cancer Invasion$62,311
U54 · FY2006 · CA · contact PI
Multiscale Mathematical Modeling of Cancer Invasion$7,920
U54 · FY2006 · CA · contact PI
Multiscale Mathematical Modeling of Cancer Invasion$2,211,727
U54 · FY2005 · CA
Cancer Biology$517,915
U54 · FY2005 · CA
Functional Studies of Laminin-5$288,875
R01 · FY2005 · GM
Multiscale Mathematical Modeling of Cancer Invasion$60,211
U54 · FY2005 · CA
Multiscale Mathematical Modeling of Cancer Invasion$2,592,133
U54 · FY2004 · CA
Cancer Biology$495,083
U54 · FY2004 · CA
INTEGRINS IN CANCER INVASION$254,452
R01 · FY2004 · CA
P.Gingivalis and Oral Keratinocyte-ECM Interactions$151,000
R21 · FY2004 · DE
INTEGRINS IN CANCER INVASION$95,681
R01 · FY2004 · CA
Second Meeting - American Society for Matrix Biology$35,000
R13 · FY2004 · DE
INTEGRINS IN CANCER INVASION$184,084
R01 · FY2003 · CA
INTEGRINS IN CANCER INVASION$170,090
R01 · FY2003 · CA
P.Gingivalis and Oral Keratinocyte-ECM Interactions$151,000
R21 · FY2003 · DE
INTEGRINS IN CANCER INVASION$119,328
R01 · FY2003 · CA
INTEGRINS IN CANCER INVASION$417,939
R01 · FY2002 · CA
Molecular Regulation of Intergrin Function$88,340
R01 · FY2002 · GM
INTEGRINS IN CANCER INVASION$67,896
R01 · FY2002 · CA
INTEGRINS IN CANCER INVASION$384,170
R01 · FY2001 · CA
Molecular Regulation of Intergrin Function$84,522
R01 · FY2001 · GM
INTEGRINS IN CANCER INVASION$35,460
R01 · FY2001 · CA
INTEGRINS IN CANCER INVASION$310,387
R01 · FY2000 · CA
MOLECULAR REGULATION OF INTEGRIN FUNCTION$265,244
R01 · FY2000 · GM